Synergetics USA Announces the Resignation of Gregg Scheller

O'FALLON, Mo.--(Business Wire)--
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it has
accepted the resignation of Gregg D. Scheller as the Company's
President, Chief Executive Officer and Chairman of the Board of
Directors, effective immediately. The Company has commenced a search
for a successor to Mr. Scheller. Robert H. Dick has been appointed
Chairman of the Board of Directors.

Ms. Juanita Hinshaw, independent member of the Board of Directors,
stated "As a founder of Synergetics and as its CEO, Gregg was
instrumental in successfully implementing the Company's growth and its
business model. We want to recognize and thank him for his many
contributions and accomplishments during his tenure as our CEO. We are
engaged in discussions with Gregg to enter into a collaborative
relationship that will allow Gregg to continue his involvement in the
Company's research and product development efforts. We look forward to
working with him in the future and to him continuing to play a
significant role in the Company's success and shaping its strategic
vision."

About Synergetics USA, Inc.

Synergetics USA is a leading medical device company focused on
progressing the standard of care for microsurgeons and their patients
by seeking to improve surgical patient outcomes through the delivery
of innovative improvements in quality, delivery and cost. The Company
focuses on the vitreoretinal, neurosurgery and ear, nose and throat
surgery markets. The distribution channels include a combination of
direct and independent sales organizations, and important strategic
alliances with market leaders.

Forward-Looking Statements

Some statements in this release may be "forward-looking
statements" for the purposes of the Private Securities Litigation
Reform Act of 1995. In some cases forward-looking statements can be
identified by words such as "believe," "expect," "anticipate," "plan,"
"potential," "continue" or similar expressions. Such forward-looking
statements include risks and uncertainties, and there are important
facts that could cause actual results to differ materially from those
expressed or implied by such forward-looking statements. These facts,
risks and uncertainties are discussed in our Annual Report on Form
10-K for the year ended July 31, 2007, as updated from time to time in
our filings with the Securities and Exchange Commission.

Synergetics USA, Inc.
Pamela G. Boone, 636-939-5100
Chief Financial Officer
investorinfo@synergeticsusa.com
or
Cameron Associates
Investor Relations
Al Palombo, 212-245-8800 Ext. 209
al@cameronassoc.com

Copyright Business Wire 2008